CervoMed Inc.
CRVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053691
No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding CervoMed Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 12 | 20 | +8 |
| Shares | 326.4K | 2.51M | +2.19M (+670.3%) |
| Value | $2.48M | $58.6M | +$56.1M (+2,260.9%) |
New holders (9)
Institutions that held CervoMed Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 861,573 | $20.1M | 0.26% |
| Armistice Capital, LLC | 734,363 | $17.1M | 0.46% |
| Ikarian Capital, LLC | 237,345 | $5.53M | 1.50% |
| Soleus Capital Management, L.P. | 126,614 | $2.95M | 0.26% |
| Crown Advisors Management, Inc. | 100,000 | $2.33M | 1.41% |
| Boothbay Fund Management, LLC | 69,014 | $1.61M | 0.05% |
| J. Goldman & Co LP | 13,500 | $314.6K | 0.01% |
| Point72 Asset Management, L.P. | 10,000 | $233.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 990 | $23.1K | 0.00% |
Sold out (1)
Institutions that held CervoMed Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 725 | $5.53K |